| dc.contributor.author | Rosain, Jeremie | |
| dc.contributor.author | Deswarte, Caroline | |
| dc.contributor.author | Hancioglu, Gonca | |
| dc.contributor.author | Oleaga-Quintas, Carmen | |
| dc.contributor.author | Kutlug, Seyhan | |
| dc.contributor.author | Kartal, Ibrahim | |
| dc.contributor.author | Bustamante, Jacinta | |
| dc.date.accessioned | 2020-06-21T12:25:54Z | |
| dc.date.available | 2020-06-21T12:25:54Z | |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 0271-9142 | |
| dc.identifier.issn | 1573-2592 | |
| dc.identifier.uri | https://doi.org/10.1007/s10875-019-00667-8 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10583 | |
| dc.description | KUZU, ISINSU/0000-0001-5519-1009 | en_US |
| dc.description | WOS: 000487139400010 | en_US |
| dc.description | PubMed: 31377971 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5R37AI095983]; Rockefeller University; St. Giles Foundation; French National Institute of Health and Medical Research (INSERM), Paris Descartes University; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French National Research Agency under the "Investments for the future" programFrench National Research Agency (ANR) [ANR-10-IAHU-01]; ANR-GENMSMDFrench National Research Agency (ANR) [ANR-16-CE17-0005-01]; SRC2017; INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm); [ANR-14-CE15-006-01] | en_US |
| dc.description.sponsorship | The Laboratory of Human Genetics of Infectious Diseases is supported by the National Institute of Allergy and Infectious Diseases grant number 5R37AI095983, the Rockefeller University, the St. Giles Foundation, the French National Institute of Health and Medical Research (INSERM), Paris Descartes University, the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID) and the French National Research Agency under the "Investments for the future" program (grant number ANR-10-IAHU-01), ANR-GENMSMD (grant number ANR-16-CE17-0005-01 for JB) and SRC2017 (for JB). COQ is financially supported by ANR-14-CE15-006-01. JR is financially supported by the INSERM PhD program for medical and pharmaceutical doctors (" poste d'accueil INSERM"). | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Springer/Plenum Publishers | en_US |
| dc.relation.isversionof | 10.1007/s10875-019-00667-8 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | LINE-1-Mediated AluYa5 Insertion Underlying Complete Autosomal Recessive IFN-gamma R1 Deficiency | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 39 | en_US |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | 739 | en_US |
| dc.identifier.endpage | 742 | en_US |
| dc.relation.journal | Journal of Clinical Immunology | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
